chartexchange

Helus Pharma to Present Topline Results from Phase 3 APPROACH Study Evaluating HLP003 as Adjunctive Treatment in Major Depressive Disorder on November 16, 2026

GlobeNewswire Inc. | Nov 15, 2026 12:00 PM EST

Company to host webcast at 8:00 a.m. EDT on Monday, November 16, 2026 Company to host webcast at 8:00 a.m. EDT on Monday, November 16, 2026

Read original article